Robotic-Assisted Eye Surgery Market CAGR Forecast Through 2030: Key Trends Shaping Industry Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Sacral Nerve Stimulation Devices Market Value Growth And Long-Term Outlook
The sacral nerve stimulation devices market has experienced rapid expansion in recent years. It is projected to increase from $1.48 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.5%. This growth in the historic period is attributable to the rising prevalence of urinary incontinence, an increasing geriatric population, advancements in neuromodulation technology, wider clinical acceptance of nerve stimulation therapies, and the expansion of urology specialty services.
The sacral nerve stimulation devices market is poised for significant expansion in the next few years. It is projected to achieve a size of $2.54 billion in 2030, advancing at a compound annual growth rate (CAGR) of 11.4%. This increase throughout the forecast period can be attributed to several factors, including the rising acceptance of smart implantable devices, an increasing requirement for long-term continence solutions, the growth of outpatient neuromodulation procedures, an intensified focus on customized neurological therapies, and growing investments in bioelectronic medicine. Key developments expected during this period involve the wider adoption of implantable neuromodulation devices, a surge in demand for less invasive bladder control treatments, the deeper integration of programmable stimulation technologies, the extension of long-term neurological therapy options, and an enhanced emphasis on patient-specific therapy customization.
Get A Free Sample Report With In-Depth Market Insights:
Sacral Nerve Stimulation Devices Market Growth Drivers: What’s Behind The Acceleration?
The rising occurrence of urological disorders is anticipated to fuel the expansion of the sacral nerve stimulation devices market moving forward. These disorders encompass a variety of conditions affecting the urinary tract, kidneys, bladder, and prostate, with their duration ranging from acute to chronic. Urological disorders can stem from various causes, impacting both the urinary tract and reproductive organs. Moreover, lifestyle elements such as an unhealthy diet, insufficient hydration, and lack of physical activity can contribute to the formation of kidney stones, a painful ailment that affects the urinary tract. Sacral nerve stimulation devices offer a minimally invasive treatment option capable of effectively managing urological conditions like urinary and fecal incontinence. For instance, data from April 2024, provided by the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based healthcare company, indicates that on average each year, 651,446 individuals aged 65 and older (consisting of 212,875 men and 438,572 women) were newly diagnosed with any form of urinary incontinence. Consequently, the increasing prevalence of urological disorders is poised to drive the growth of the sacral nerve stimulation devices market.
Sacral Nerve Stimulation Devices Market Segment Landscape: Which Areas Lead Development?
The sacral nerve stimulation devices market covered in this report is segmented –
1) By Technology Modality: Implantable Sacral Neuromodulation, External Sacral Neuromodulation
2) By Product: External Sacral Nerve Stimulation Devices, Implantable Sacral Nerve Stimulation Devices
3) By Age Group: Pediatrics, Adults, Geriatrics
4) By Application: Urinary Incontinence, Fecal Incontinence, Bowel Dysfunction, Other Applications
5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Subsegments:
1) By Implantable Sacral Neuromodulation: Rechargeable Implantable SNS Systems, Non-Rechargeable Implantable SNS Systems
2) By External Sacral Neuromodulation: Transcutaneous Sacral Neuromodulation Systems, Wearable External Neuromodulation Devices
Sacral Nerve Stimulation Devices Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies active in the Sacral Nerve Stimulation (SNS) devices market are concentrating on developing innovative products, such as sacral neuromodulation systems that operate without requiring a recharge, to enhance patient convenience and ensure greater therapy adherence. Recharge-free sacral neuromodulation systems are implantable devices that work by stimulating the sacral nerves to address bladder and bowel dysfunction, eliminating the need for regular battery recharging. As an illustration, in January 2025, Medtronic PLC, an Ireland-based medical technology company, secured FDA approval for its InterStim X Sacral Neuromodulation (SNM) system in India. This system is approved for treating bladder and bowel control issues, including overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. These systems are equipped with a unique fifth-generation battery that provides more than 10 years of therapy without requiring a charge, and this can extend up to 15 years when set to low-energy modes. A smart programmer, designed to resemble a smartphone, is included, allowing patients to discreetly adjust up to 11 therapy settings on their own, whether at home or on the move. Additionally, the system features SureScan MRI technology, which enables patients to undergo safe full-body 1.5T and 3T MRI scans, with the MRI mode being easily controllable by the patient under professional medical guidance.
Sacral Nerve Stimulation Devices Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Neuspera Medical, Coloplast Group, Medtronic Neurovascular, NeuroPace Inc., Aleva Neurotherapeutics, LivaNova Neuromodulation, Nalu Medical, SetPoint Medical, NeuroSigma Inc., Saluda Medical, Soterix Medical, Inspire Medical Systems Inc., Synapse Biomedical Inc., Bioinduction Ltd
View The Full Sacral Nerve Stimulation Devices Market Report:
Sacral Nerve Stimulation Devices Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the sacral nerve stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
